Effect of Exenatide, Sitagliptin, or Glimepiride on Β-Cell Secretory Capacity in Early Type 2 Diabetes
Diabetes Care - United States
doi 10.2337/dc14-0398
Full Text
Open PDFAbstract
Available in full text
Date
June 26, 2014
Authors
Publisher
American Diabetes Association